Bellerophon Makes Two Important Announcements For Pulmonary Arterial Hypertension Therapy Program INOpulse
News, Pulmonary Hypertension
Last week, Bellerophon Therapeutics, Inc., (Nasdaq:BLPH), a clinical-stage biotherapeutics company focused on developing therapies that address significant unmet medical needs in the treatment of cardiopulmonary and cardiac diseases, made two ... Read more